Alternative microexon splicing code for a four-amino acid peptide of PTPRD governs behavioral development
Abstract
Microexons of 3 to 27 nucleotides selectively regulated in the vertebrate nervous system have attracted attention as new elements for modifying the function of neuronal proteins. Protein tyrosine phosphatase δ (PTPRD) is one of presynaptic hubs for neuronal synaptic organization. Alternative splicing (AS) of three microexons, meA3, meA6, and meB, encoding 3, 6, and 4 amino acid-peptides, respectively, imparts structural diversity to PTPRD, due to which the resulting eight splice variants exhibit distinct synaptogenic properties. However, the regulatory mechanisms of AS and physiological significance of the AS code for Ptprd gene remain largely unknown. Here, we report the AS of the three microexons is genetically regulated to generate spatiotemporally distinct expression pattern of eight Ptprd splice variants across brain regions and is modulated by neuronal activity. We identified both the intronic splicing enhancer region (ISE) for meB contributing to the spatiotemporal patterning of the AS and the neuronal activity–dependent intronic splicing silencer region for meB (ISS). Heterozygous deletion of the ISE in mice led to a decreased meB selection rate by ~25% with unaltered total amount of PTPRD protein and caused severe sensory, motor, social, and emotional behavioral abnormalities but no obvious changes in learning and memory, while heterozygous Ptprd knockout mice with unaltered meB selection rate and ~50% decrease in total PTPRD protein showed much fewer behavioral abnormalities. Interestingly, deletion of the ISS for meB caused selective impairments in motor learning and fear memory. Our findings demonstrate the spatiotemporal and activity-dependent AS code for Ptprd meB plays a crucial role in proper behavioral development.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (14)
Ayako Imai
Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
Hironori Izumi
Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
Nagomi Ito
Department of Molecular Neuroscience, Interdisciplinary Graduate School of Medicine, Pharmacy, Sciences and Engineering, University of Toyama
Hina Ogiso
Department of Biofunctional Molecular Chemistry, Faculty of Engineering, University of Toyama
Yuki Kitajima
Department of Biological Information Processing, Graduate School of Science and Engineering, University of Toyama
Shuhei Kawase
Department of Biological Information Processing, Graduate School of Science and Engineering, University of Toyama
Mizuki Sendo
Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
Kenji Azechi
Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
Toshihide Tabata
Department of Biological Information Processing, Graduate School of Science and Engineering, University of Toyama
Yumie Koshidaka
Life Science Research Center, University of Toyama
Shuya Fukai
Department of Chemistry, Graduate School of Science, Kyoto University
Keizo Takao
Research Center for Idling Brain Science, University of Toyama
Hisashi Mori
Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
Tomoyuki Yoshida
Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama